Stocks / NASDAQ / RXi Pharmaceuticals Corporation

RXi Pharmaceuticals Corporation

Our Opinion

RXi Pharmaceuticals Corporation is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“The data presented establish the efficacy of locally administered sd-rxRNAs in animal models and support the use of these novel compounds for clinical applications where the direct or local administration is possible, thereby potentially enabling broad opportunities for therapeutic development using local administration routes.” Read the following article

Company Description

RXi Pharmaceuticals Corporation, incorporated on October 8, 2011, is a clinical-stage ribonucleic acid (RNA) interference (RNAi) company developing therapeutics in dermatology and ophthalmology that address unmet medical needs. The Company’s development programs are based on its self-delivering RNAi (sd-rxRNA) platform and Samcyprone, a topical immunomodulator. [Source: Reuters]

Company Website: